GET THE APP

Journal of Leukemia

Journal of Leukemia
Open Access

ISSN: 2329-6917

+44 1300 500008

Journal of Leukemia : Citations & Metrics Report

Articles published in Journal of Leukemia have been cited by esteemed scholars and scientists all around the world. Journal of Leukemia has got h-index 11, which means every article in Journal of Leukemia has got 11 average citations.

Following are the list of articles that have cited the articles published in Journal of Leukemia.

  2021 2020 2019 2018 2017 2016

Year wise published articles

62 23 11 8 22 23

Year wise citations received

54 59 64 98 109 74
Journal total citations count 618
Journal impact factor 2.11
Journal 5 years impact factor 3.71
Journal cite score 3.91
Journal h-index 11
Journal h-index since 2018 8
Important citations (462)

almarza cc. the clinical practice of embodied care: a phenomenological examination of physician-family interactions in oncological treatment (doctoral dissertation, education: faculty of education).

Timilshina n, breunis h, tomlinson ga, brandwein jm, buckstein r, durbano s, alibhai sm. long-term recovery of quality of life and physical function over three years in adult survivors of acute myeloid leukemia after intensive chemotherapy. leukemia. 2019 jan;33(1):15.

Stein e, xie j, duchesneau e, bhattacharyya s, vudumula u, ndife b, bonifacio g, guerin a, li n, joseph g. cost effectiveness of midostaurin in the treatment of newly diagnosed flt3-mutated acute myeloid leukemia in the united states. pharmacoeconomics. 2019 feb 13;37(2):239-53.

Liu fr, jin h, wang y, chen c, li m, mao sj, wang q, li h. anti-cd123 antibody-modified niosomes for targeted delivery of daunorubicin against acute myeloid leukemia. drug delivery. 2017 jan 1;24(1):882-90.

Li y, zhang m, sheng m, zhang p, chen z, xing w, bai j, cheng t, yang fc, zhou y. therapeutic potential of gsk-j4, a histone demethylase kdm6b/jmjd3 inhibitor, for acute myeloid leukemia. journal of cancer research and clinical oncology. 2018 jun 1;144(6):1065-77.

Özbolat g, tuli a. demir fazlalÃ?±Ã?ŸÃ?± Ã?°çin Ã?želasyon tedavisi ve Ã?želasyon ligandlarÃ?±. arÃ?Ÿiv kaynak tarama dergisi. 2019;28(1):66-81.

Santosh k. review on thalassemia. biochemistry molecular biology letters. 2017;3(2):1-0.

The impact of silymarin on antioxidant and oxidative status in patients with ?-thalassemia major: a crossover, randomized controlled trial

veloso as. micro rnas e mieloma múltiplo (doctoral dissertation).

Nicolas batty md. facp fascp, young yin phd (2015) a need of metrics in cancer economics: myth or hope. j can epi treat.;1(1):11-2.

Gv rr. types of cancer and surgery in rats (rattus norvegicus). growth.;91:95.

Network analysis of micrornas, genes and their regulation in diffuse and follicular b-cell lymphomas

Microrna-155 hallmarks promising accuracy for the diagnosis of various carcinomas: results from a meta-analysis

Circulating mir-95 is a potential biomarker of chronic lymphocytic leukemia

Impact of microrna in different diseases and cancer

shukla p. umbilical cord preservation-a review. biochem mol biol lett. 2017;3(1):109.

heckl bc. the molecular function of mll/af4 for patient derived acute leukemias growing in mice (doctoral dissertation, technische universität münchen).

barth bm, wang w, toran pt, fox te, annageldiyev c, ondrasik rm, keasey nr, brown tj, devine vg, sullivan ec, cote al. sphingolipid metabolism determines the therapeutic efficacy of nanoliposomal ceramide in acute myeloid leukemia. blood advances. 2019 sep 5;3(17):2598-603.

tan sf, liu x, fox te, barth bm, sharma a, turner sd, awwad a, dewey a, doi k, spitzer b, shah mv. acid ceramidase is upregulated in aml and represents a novel therapeutic target. oncotarget. 2016 dec 13;7(50):83208.

shukla p. umbilical cord preservation-a review. biochem mol biol lett. 2017;3(1):109.

Relevant Topics

Top